Mandate Skandia Investment and Investor Growth Capital acquire Swedish Orphan International

May 12, 2005

A consortium comprising of Investor Growth Capital (IGC), Skandia Investment (SI), the Swedish private equity firms and the CEO of Swedish Orphan International AB (SOI) have agreed to acquire the company. SOI is a Sweden based company with the business concept to develop, register, market and distribute orphan drugs, which are pharmaceuticals used in the treatment of rare disorders, for an undisclosed sum.

Vinge acted for Investor Growth Capital and Skandia Investment.
Ulf Sallnäs (responsible partner)
Helena Dandenell, Kristoffer Persson (associates)

Insurance law and blockage of the Suez Canal

One of the largest container ships in the world is still blocking the Suez Canal, an event which can have significant global consequences. Even Swedish interested parties such as the Port of Gothenburg may also be affected by the situation. The running aground is a clear reminder of the vulnerability of global transport chains, and sheds light on a number of important insurance issues.
March 29, 2021

Vinge top-ranked by Chambers & Partners within ten practice areas

Vinge would like to thank all the clients who have contributed with their time through the interview processes for Chambers’ annual rankings. We have today received the result, and we are delighted with top rankings in 13 areas and a significant number of individual rankings.
March 19, 2021

Vinge’s Managing Partner Maria-Pia Hope is chosen as one of the most powerful women in Swedish business by Dagens Industri

Maria Pia Hope, Managing Partner at Vinge, stands out as one of the few lawyers on the list when Dagens Industri presents its list of the most powerful women in business.
March 08, 2021